Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study highlights differences in how epilepsy is diagnosed
One in 160 dogs under first opinion veterinary care are affected every year by seizures.
VetCompass research supports calls for clearer diagnostic guidelines. 

Substantial differences between how veterinary clinicians diagnose epilepsy compared with current guidelines have been highlighted in new research. 

Researchers say their study, published in the Journal of Veterinary Internal Medicine, supports the call for clearer diagnostic guidelines for application in clinical practice.

The study reveals that around one in every 160 dogs under first opinion veterinary care are affected every year by seizures. Many of these dogs have underlying epilepsy, defined as dogs with two or more unprovoked seizures at least 24 hours apart. 

The study was led by the Royal Veterinary College’s VetCompass™ programme.

Study author Dr Dan O’Neill, senior lecturer in companion animals epidemiology at the Royal Veterinary College (RVC), said: “Watching your dog undergo a seizure can be an incredibly scary moment for any dog owner. It is really important that dogs that seizure are rapidly diagnosed to decide whether they need no further treatment beyond careful monitoring or alternatively require a clinical work-up to define the cause of the seizures. 

“There are now some excellent treatments for many seizure-related diseases. This study helps up to understand the current state of play for seizure management in dogs and identifies opportunities for improved care of these affected dogs.”

Currently, little information exists on the classifications of seizures, diagnostic approaches, or clinical management of dogs with seizures in the veterinary first opinion population.  

For the study, researchers assessed clinical records from first-opinion clinics across the UK. The team identified 2,834 incident seizure cases from a population of 455,553 dogs attending VetCompass™ participating practices during 2013.

The most common breeds among seizure cases were Labrador retrievers (8.6%), Staffordshire bull terriers (6.1%), Jack Russell terriers (5.8%) and Yorkshire terriers (5.0%), with the annual incidence risk of seizures in all dogs being 0.62 per cent.

Researchers also found that 579 (20.5%) of seizure cases met the criteria for epilepsy based on the International Veterinary Epilepsy Task Force (IVETF) classification system, compared with just 245 (8.6%) that were formally recorded with epilepsy by the attending veterinary team.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.